Excess exposure to insulin is the primary cause of insulin resistance and its associated atherosclerosis

Current Molecular Pharmacology

Volumn 4, Issue 3, 2011, Pages 154-166

  Cao, Wenhong ^a,b   Ning, Jie ^a,c   Yang, Xuefeng ^a,d   Liu, Zhenqi ^e  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^c The 2nd People's Hospital of Hunan Province   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Diabetes; Insulin; Insulin resistance; Insulin sensitivity; Obesity

Indexed keywords

FATTY ACID; INSULIN;

ATHEROSCLEROSIS; AUTOPHAGY; BIODEGRADATION; BIOGENESIS; CAROTID ATHEROSCLEROSIS; DEATH; DRUG EXPOSURE; ECTOPIC ORGAN; FATTY ACID BLOOD LEVEL; FIBROSIS; FOAM CELL; FOOD; FOOD INTAKE; HEART INFARCTION; HORMONAL REGULATION; HUMAN; HYPERINSULINEMIA; INFLAMMATION; INSULIN DEFICIENCY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESPAN; LIPID STORAGE; MITOCHONDRION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEDENTARY LIFESTYLE; STROKE; THROMBOSIS;

ATHEROSCLEROSIS; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; MITOCHONDRIA; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 80053586942     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467211104030154     Document Type: Review

References (155)

1. Accili D. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes, 2004, 53(7), 1633-1642.
2. Burns, J.M.; Donnelly, J.E; Anderson, H.S.; Mayo, M.S.; Spencer- Gardner, L.; Thomas, G.; Cronk, B.B.; Haddad, Z.; Klima, D.; Hansen, D.; Brooks, W.M. Peripheral insulin and brain structure in early Alzheimer disease. Neurology, 2007, 699(11), 1094-1104.
3. Cole, G.M.; Frautschy, S.A. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease. Exp. Gerontol., 2007, 42, 10-21.
4. Crowell, J.A.; Steele, V.E.; Fay, J.R. Targeting the AKT protein kinase for cancer chemoprevention. Mol. Cancer Ther., 2007, 6, 2139-2148.
5. Moreira, P.I.; Santos, M.S.; Seica, R.; Oliveira, C.R. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes. J. Neurol. Sci., 2007, 257, 206-214.
6. Al-Shawwa, B.A.; Al-Huniti, N.H.; DeMattia, L.; Gershan, W. Asthma and insulin resistance in morbidly obese children and adolescents. J. Asthma, 2007, 44, 469-473.
7. Sterry, W.; Strober, B.E.; Menter, A. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br. J. Dermatol., 2007, 157, 649-655.
8. Popa, C.; Netea, M.G.; van Riel, P.L.; van der Meer, J.W.; Stalenhoef, A.F. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J. Lipid Res., 2007, 48, 751-762.
9. Okazaki, R. Links between osteoporosis and atherosclerosis; beyond insulin resistance. Clin. Calcium, 2008, 18, 638-643.
10. Liu, H.; Hong, T.; Wen, G.B.; Han, J.; Zuo, D.; Liu, Z.; Cao, W. Increased basal level of Akt-dependent insulin signaling may be responsible for the development of insulin resistance. Am. J. Physiol. Endocrinol. Metab., 2009, 297, E898-E906.
11. Maassen, J.A.; t Hart, L.M.; Ouwens, D.M. Lessons that can be learned from patients with diabetogenic mutations in mitochondrial DNA: implications for common type 2 diabetes. Curr. Opin. Clin. Nutr. Metab. Care, 2007, 10, 693-697.
12. Rasouli, N.; Molavi, B.; Elbein, S.C.; Kern, P.A. Ectopic fat accumulation and metabolic syndrome. Diabetes Obes. Metab., 2007, 9, 1-10.
13. Kim, J.Y.; van de Wall, E.; Laplante, M.; Azzara, A.; Trujillo, M.E.; Hofmann, S.M.; Schraw, T.; Durand, J.L.; Li, H.; Li, G.; Jelicks, L.A.; Mehler, M.F.; Hui, D.Y.; Deshaies, Y.; Shulman, G.I.; Schwartz, G.J.; Scherer, P.E. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest., 2007, 117, 2621-2637.
14. Wang, M.Y.; Grayburn, P.; Chen, S.; Ravazzola, M.; Orci, L.; Unger, R.H. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc. Natl. Acad. Sci. USA, 2008, 105, 6139-6144.
15. Ishii, S.; Iizuka, K.; Miller, B.C.; Uyeda, K. 2004 Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc. Natl. Acad. Sci. USA, 2008, 101, 15597-15602.
16. Arsham, A.M.; Neufeld, T.P. Thinking globally and acting locally with TOR. Curr. Opin. Cell Biol., 2006, 18, 589-597.
17. Ono, H.; Shimano, H.; Katagiri, H.; Yahagi, N.; Sakoda, H.; Onishi, Y.; Anai, M.; Ogihara, T.; Fujishiro, M.; Viana, A.Y.; Fukushima, Y.; Abe, M.; Shojima, N.; Kikuchi, M.; Yamada, N.; Oka, Y.; Asano, T. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement. Diabetes, 2003, 52, 2905-2913.
18. Goodwin, B.J.; Zuercher, W.J.; Collins, J.L. Recent advances in liver X receptor biology and chemistry. Curr. Top. Med. Chem., 2008, 8, 781-791.
19. Girard, J.; Perdereau, D.; Foufelle, F.; Prip-Buus, C.; Ferre, P. Regulation of lipogenic enzyme gene expression by nutrients and hormones. FASEB J., 1994, 8, 36-42
20. Nemeth, P.M.; Rosser, B.W.; Choksi, R.M.; Norris, B.J.; Baker, K.M. Metabolic response to a high-fat diet in neonatal and adult rat muscle. Am. J. Physiol., 1992, 262, C282-C286.
21. Katic, M.; Kennedy, A.R.; Leykin, I.; Norris, A.; McGettrick, A.; Gesta, S.; Russell, S.J.; Bluher, M.; Maratos-Flier, E.; Kahn, C.R. Mitochondrial gene expression and increased oxidative metabolism: role in increased lifespan of fat-specific insulin receptor knock-out mice. Aging Cell, 2007, 6, 827-839.
22. Duff, G.L.; Mc, M.G. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. J. Exp. Med., 1949, 89, 611-630.
23. Duff, G.L.; Payne, T.P. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. III. The mechanism of the inhibition of experimental cholesterol atherosclerosis in alloxan-diabetic rabbits. J. Exp. Med., 1950, 92, 299-317.
24. Duff, G.L.; Brechin, D.J.; Finkelstein, W.E. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV. The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit. J. Exp. Med., 1954, 100, 371-380.
25. Stamler, J.; Pick, R.; Katz, L.N. Effect of insulin in the induction and regression of atherosclerosis in the chick. Circ. Res., 1960, 8, 572-576.
26. Cruz, A.B. Jr.; Amatuzio, D.S.; Grande, F.; Hay, L.J. Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxandiabetic dogs. Circ. Res., 1961, 9, 39-43.
27. Ye, J. Role of insulin in the pathogenesis of free fatty acid-induced insulin resistance in skeletal muscle. Endocr. Metab. Immune Disord. Drug Targets, 2007, 7, 65-74.
28. Wullaert, A.; van Loo, G.; Heyninck, K.; Beyaert, R. Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond. Endocr. Rev., 2007, 28, 365-386.
29. Kaneto, H.; Matsuoka, T.A.; Katakami, N.; Kawamori, D.; Miyatsuka, T.; Yoshiuchi, K.; Yasuda, T.; Sakamoto, K.; Yamasaki, Y.; Matsuhisa, M. Oxidative Stress and the JNK Pathway are Involved in the Development of Type 1 and Type 2 Diabetes. Curr. Mol. Med., 2007, 7, 674-686.
30. Manning, B.D. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J. Cell Biol., 2004, 167, 399-403.
31. Gregor, M.F.; Hotamisligil, G.S. Thematic review series: Adipocyte Biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J. Lipid Res., 2007, 48, 1905-1914.
32. Houstis, N.; Rosen, E.D.; Lander, E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature, 2006, 440, 944-948.
33. Pospisilik, J.A.; Knauf, C.; Joza, N.; Benit, P.; Orthofer, M.; Cani, P.D; Ebersberger, I.; Nakashima, T.; Sarao, R.; Neely, G.; Esterbauer, H.; Kozlov, A.; Kahn, C.R.; Kroemer, G.; Rustin, P.; Burcelin, R.; Penninger, J.M. Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell, 2007, 131, 476-491.
34. Kumashiro, N.; Tamura, Y.; Uchida, T.; Ogihara, T.; Fujitani, Y.; Hirose, T.; Mochizuki, H.; Kawamori, R.; Watada, H. Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance. Diabetes, 2008, 57, 2083-2091.
35. Matsuzawa-Nagata, N.; Takamura, T.; Ando, H.; Nakamura, S.; Kurita, S.; Misu, H.; Ota, T.; Yokoyama, M.; Honda, M.; Miyamoto, K.; Kaneko, S. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism, 2008, 57, 1071-1077.
36. Schenk, S.; Horowitz, J.F. Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J. Clin. Invest., 2007, 117, 1690-1698.
37. Monetti, M.; Levin, M.C; Watt, M.J.; Sajan, M.P.; Marmor, S.; Hubbard, B.K.; Stevens, R.D.; Bain, J.R.; Newgard, C.B.; Farese, R.V. Sr.; Hevener, A.L.; Farese, R.V. Jr. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab., 2007, 6, 69-78.
38. Evans, J.L.; Goldfine, I.D.; Maddux, B.A.; Grodsky, G.M. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr. Rev., 2002, 23, 599-622.
39. Cheng, Z.; Tseng, Y.; White, M.F. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol. Metab., 2010, 21, 589-598.
40. Wallace, D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet., 2005, 39, 359-407.
41. Loschen, G.; Flohe, L.; Chance, B. Respiratory chain linked H(2)O(2) production in pigeon heart mitochondria. FEBS Lett., 1971, 18, 261-264.
42. Yang, Z.; Cheng, W.; Hong, L.; Chen, W.; Wang, Y.; Lin, S.; Han, J.; Zhou, H.; Gu, J. Adenine nucleotide (ADP/ATP) translocase 3 participates in the tumor necrosis factor induced apoptosis of MCF-7 cells. Mol. Biol. Cell, 2007, 18, 4681-4689.
43. Tai, E.S.; Ordovas, J.M. The role of perilipin in human obesity and insulin resistance. Curr. Opin. Lipidol., 2007, 18, 152-156.
44. Wojtczak, L.; Zaluska, H. The inhibition of translocation of adenine nucleotides through mitochondrial membranes by oleate. Biochem. Biophys. Res. Commun., 1967, 28, 76-81.
45. Lerner, E.; Shug, A.L.; Elson, C.; Shrago, E. Reversible inhibition of adenine nucleotide translocation by long chain fatty acyl coenzyme A esters in liver mitochondria of diabetic and hibernating animals. J. Biol. Chem., 1972, 247, 1513-1519.
46. Shug, A.L.; Shrago, E.; Bittar, N.; Folts, J.D.; Koke, J.R. Acyl- CoA inhibition of adenine nucleotide translocation in ischemic myocardium. Am. J. Physiol., 1975, 228, 689-692.
47. Pande, S.V.; Blanchaer, M.C. Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl coenzyme A esters. J. Biol. Chem., 1971, 246, 402-411.
48. Shrago, E.; Shu, A.; Elson, C. Regulation of cell metabolism by mitochondrial transport systems. Gluconeogenesis: Its regulation in mammalian species Editored by Richard W. Hanson, published by John Wiley & Sons: 1976, pp. 221-238.
49. Barja, G. Mitochondrial oxygen consumption and reactive oxygen species production are independently modulated: implications for aging studies. Rejuvenation Res., 2007, 10, 215-224.
50. Pomplun, D.; Voigt, A.; Schulz, T.J; Thierbach, R.; Pfeiffer, A.F.; Ristow, M. Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity. Proc. Natl. Acad. Sci. USA, 2007, 104, 6377-81.
51. Petersen, K.F.; Dufour, S.; Befroy, D.; Garcia, R.; Shulman, G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med., 2004, 350, 664-671.
52. Maassen, J.A.; 'T Hart, L.M.; Van Essen, E.; Heine, R.J.; Nijpels, G.; Jahangir Tafrechi, R.S.; Raap, A.K.; Janssen, G.M.; Lemkes, H.H. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes, 2004, 53(Suppl. 1), S103-S109.
53. Lillioja, S.; Young, A.A.; Culter, C.L.; Ivy, J.L.; Abbott, W.G.; Zawadzki J.K.; Yki-Järvinen, H.; Christin, L.; Secomb, T.W; Bogardus, C. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J. Clin. Invest., 1987, 80, 415-424.
54. Marin, P.; Andersson, B.; Krotkiewski, M.; Bjorntorp, P. Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care, 1994, 17, 382-386.
55. Bogacka, I.; Xie, H.; Bray, G.A.; Smith, S.R. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo. Diabetes, 2005, 54, 1392-1399.
56. van der Valk, M.; Casula, M.; Weverlingz, G.J.; van Kuijk, K.; van Eck-Smit, B.; Hulsebosch, H.J.; Nieuwkerk, P.; van Eeden, A.; Brinkman, K.; Lange, J.; de Ronde, A.; Reiss, P. Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy. Antivir. Ther., 2004, 9, 385-393.
57. Antonetti, D.A.; Reynet, C.; Kahn, C.R. Increased expression of mitochondrial-encoded genes in skeletal muscle of humans with diabetes mellitus. J. Clin. Invest., 1995, 95, 1383-1388.
58. Wilding, J.P. The importance of free fatty acids in the development of Type 2 diabetes. Diabet. Med., 2007, 24, 934-945.
59. Garcia-Roves, P.; Huss, J.M.; Han, D.H.; Hancock, C.R.; Iglesias- Gutierrez, E.; Chen, M.; Holloszy, J.O. Raising plasma fatty acid concentration induces increased biogenesis of mitochondria in skeletal muscle. Proc. Natl. Acad. Sci. USA, 2007, 104, 10709-10713.
60. Steinberg, G.R. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle, 2007, 6, 888-894.
61. Puigserver, P.; Rhee, J.; Lin, J.; Wu, Z.; Yoon, J.C.; Zhang, C.Y.; Krauss, S.; Mootha, V.K.; Lowell, B.B.; Spiegelman B.M. Cytokine Stimulation of Energy Expenditure through p38 MAP Kinase Activation of PPAR Coactivator-1. Mol. Cell, 2001, 8, 971-82.
62. Shimizu, I.; Minamino, T.; Toko, H.; Okada, S.; Ikeda, H.; Yasuda, N.; Tateno, K.; Moriya, J.; Yokoyama, M.; Nojima, A.; Koh, G.Y.; Akazawa, H.; Shiojima, I.; Kahn, C.R.; Abel, E.D.; Komuro, I. Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J. Clin. Invest., 2010, 120, 1506-1514.
63. Liu, H.Y.; Yehuda-Shnaidman, E.; Hong, T.; Han, J.; Pi, J.; Liu, Z.; Cao, W. Prolonged exposure to insulin suppresses mitochondrial production in primary hepatocytes. J. Biol. Chem., 2009, 284, 14087-14095.
64. Liu, H.Y.; Cao, S.Y.; Han, J.; Liu, Z.; Cao, W. Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with Type 1 diabetes mellitus (T1DM). J. Biol. Chem., 2009, 284, 27090-27100.
65. Holzenberger, M.; Dupont, J.; Ducos, B.; Leneuve, P.; Géloën, A.; Even, P.C.; Cervera, P.; Le Bouc, Y. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature, 2003, 421, 182-187.
66. Al-Regaiey, K.A.; Masternak, M.M.; Bonkowski, M.; Sun, L.; Bartke, A. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology, 2005, 146, 851-860.
67. Civitares, A.E.; Carling, S.; Heilbronn, L.K.; Hulver, M.H.; Ukropcova, B.; Deutsch, W.A.; Smith, S.R.; Ravussin, E.; CALERIE Pennington Team. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med., 2007, 4, e76.
68. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006, 127, 1109-1122.
69. Milne, J.C.; Lambert, P.D.; Schenk, S.; Carney, D.P.; Smith, J.J.; Gagne, D.J.; Jin, L.; Boss, O.; Perni, R.B.; Vu, C.B.; Bemis, J.E.; Xie, R.; Disch, J.S.; Ng, P.Y.; Nunes, J.J.; Lynch, A.V.; Yang, H.; Galonek, H.; Israelian, K.; Choy, W.; Iffland, A.; Lavu, S.; Medvedik, O.; Sinclair, D.A.; Olefsky, J.M.; Jirousek, M.R.; Elliott, P.J.; Westphal, C.H. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 2007, 450, 12-16.
70. Salih, D.A.; Brunet, A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell. Biol., 2008, 20, 126-136.
71. Yin, X.M.; Ding, W.X.; Gao, W. Autophagy in the liver. Hepatology, 2008, 47, 1773-1785.
72. Droge, W.; Kinscherf, R. Aberrant insulin receptor signaling and amino acid homeostasis as a major cause of oxidative stress in aging. Antioxid. Redox. Signal., 2008, 10, 661-678.
73. Meijer, A.J.; Codogno, P. Macroautophagy: protector in the diabetes drama? Autophagy, 2007, 3, 523-526.
74. Liu, H.Y.; Han, J.; Cao, S.Y.; Hong, T.; Zhuo, D.; Shi, J.; Liu, Z.; Cao, W. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin. J. Biol. Chem., 2009, 284, 31484-31492.
75. Yang, L.; Li, P.; Fu, S.; Calay, E.S.; Hotamisligil, G.S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab., 2010, 11, 467-478.
76. Dworakowski, R.; Anilkumar, N.; Zhang, M.; Shah, A.M. Redox signalling involving NADPH oxidase-derived reactive oxygen species. Biochem. Soc. Trans., 2006, 34, 960-964.
77. Stumpo, D.J.; Kletzien, R.F. Regulation of glucose-6-phosphate dehydrogenase mRNA by insulin and the glucocorticoids in primary cultures of rat hepatocytes. Eur. J. Biochem., 1984, 144, 497-502.
78. Stumpo, D.J.; Kletzien, R.F. The effect of ethanol, alone and in combination with the glucocorticoids and insulin, on glucose-6- phosphate dehydrogenase synthesis and mRNA in primary cultures of hepatocytes. Biochem. J., 1985, 226, 123-130.
79. Fritz, R.S.; Stumpo, D.J.; Kletzien, R.F. Glucose-6-phosphate dehydrogenase mRNA sequence abundance in primary cultures of rat hepatocytes. Effect of insulin and dexamethasone. Biochem. J., 1986, 237, 617-619.
80. San Jose, G.; Bidegain, J.; Robador, P.A.; Diez, J.; Fortuno, A.; Zalba, G. Insulin-induced NADPH oxidase activation promotes proliferation and matrix metalloproteinase activation in monocytes/ macrophages. Free Radic. Biol. Med., 2009, 46, 1058-1067.
81. Ceolotto, G.; Bevilacqua, M.; Papparella, I.; Baritonol E.; Franco, L.; Corvaja, C.; Mazzoni, M.; Semplicini, A.; Avogaro, A. Insulin generates free radicals by an NAD(P)H, phosphatidylinositol 3'- kinase-dependent mechanism in human skin fibroblasts ex vivo. Diabetes, 2004, 53, 1344-1351.
82. Zhuang, D.; Ceacareanu, A.C.; Lin, Y.; Ceacareanu, B.; Dixit, M.; Chapman, K.E.; Waters, C.M.; Rao, G.N.; Hassid, A. Nitric oxide attenuates insulin- or IGF-I-stimulated aortic smooth muscle cell motility by decreasing H2O2 levels: essential role of cGMP. Am. J. Physiol. Heart Circ. Physiol., 2004, 286, H2103-H2112.
83. Krieger-Brauer, H.I.; Kather, H. Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase. J. Clin. Invest., 1992, 89, 1006-10013.
84. Mahadev, K.; Motoshima, H.; Wu, X.; Ruddy, J.M.; Arnold, R.S.; Cheng, G.; Lambeth, J.D.; Goldstein, B.J. The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transduction. Mol. Cell Biol., 2004, 24, 1844-1854.
85. Zorov, D.B.; Filburn, C.R.; Klotz, L.O.; Zweier, J.L.; Sollott, S.J. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J. Exp. Med., 2000, 192, 1001-1014.
86. Kops, G.J.; Dansen, T.B.; Polderman, P.E.; Saarloos, I.; Wirtz, K.W.A.; Coffer, P.J.; Huang, T-.T.; Bos, J.L.; Medema, R.H.; Burgering, B.M.T. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature, 2002, 419, 316-321.
87. Huang, H.; Tindall, D.J. Dynamic FoxO transcription factors. J. Cell Sci., 2007, 120, 2479-2487.
88. Radojicic, R.; Cvijic, G.; Djordjevic, J.; Djurasevic, S.; Davidovic, V. Chronic effect of insulin on monoamine oxidase and antioxidant enzyme activities in the rat brainstem. Comp. Biochem. Physiol. C. Pharmacol. Toxicol. Endocrinol., 1997, 117, 187-192.
89. Plum, L.; Ma, X.; Hampel, B.; Balthasar, N.; Coppari, R.; Münzberg, H.; Shanabrough, M.; Burdakov, D.; Rother, E.; Janoschek, R.; Alber, J.; Belgardt, B.F.; Koch, L.; Seibler, J.; Schwenk, F.; Fekete, C.; Suzuki, A.; Mak, T.W.; Krone, W.; Horvath, T.L.; Ashcroft, F.M.; Brüning, J.C. Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity. J. Clin. Invest., 2006, 116, 1886-1901.
90. Tsuchida, A.; Yamauchi, T.; Ito, Y.; Hada, Y.; Maki, T.; Takekawa, S.; Kamon, J.; Kobayashi, M.; Suzuki, R.; Hara, K.; Kubota, N.; Terauchi, Y.; Froguel, P.; Nakae, J.; Kasuga, M.; Accili, D.; Tobe, K.; Ueki, K.; Nagai, R.; Kadowaki, T. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J. Biol. Chem., 2004, 279, 30817-30822.
91. Knopp, R.H.; d'Emden, M.; Smilde, J.G.; Pocock, S.J. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care, 2006, 29, 1478-1485.
92. Stout, R.W. Insulin stimulation of cholesterol synthesis by arterial tissue. Lancet, 1969, 2, 467-468.
93. Stout, R.W. Insulin stimulation of cholesterol synthesis by arterial tissue. Lancet, 1970, 1, 248.
94. Stout, R.W. The effect of insulin on the incorporation of sodium (1- 14 C)-acetate into the lipids of the rat aorta. Diabetologia, 1971, 7, 367-372.
95. Boren, J.; Olin, K.; Lee, I.; Chait, A.; Wight, T.N.; Innerarity, T.L. Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding. J. Clin. Invest., 1998, 101, 2658-2664.
96. Flood, C.; Gustafsson, M.; Richardson, P.E.; Harvey, S.C.; Segrest, J.P.; Boren, J. Identification of the proteoglycan binding site in apolipoprotein B48. J. Biol. Chem., 2002, 277, 32228-32233.
97. Flood, C.; Gustafsson, M.; Pitas, R.E.; Arnaboldi, L.; Walzem, R.L.; Boren, J. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100. Arterioscler. Thromb. Vasc. Biol., 2004, 24, 564-570.
98. Lusis, A.J. Atherosclerosis. Nature, 2000, 407, 233-241.
99. Gimbrone, M.A. Jr. Vascular endothelium, hemodynamic forces, and atherogenesis. Am. J. Pathol., 1999, 155, 1-5.
100. Stassen, F.R.; Vainas, T.; Bruggeman, C.A. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol. Rep., 2008, 60, 85-92.
101. Xu, L.; Badr, M.Z. Enhanced potential for oxidative stress in hyperinsulinemic rats: imbalance between hepatic peroxisomal hydrogen peroxide production and decomposition due to hyperinsulinemia. Horm. Metab. Res., 1999, 31, 278-282.
102. Mahadev, K.; Wu, X.; Zilbering, A.; Zhu, L.; Lawrence, J.T.; Goldstein, B.J. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J. Biol. Chem., 2001, 276, 48662-48669.
103. Kletzien, R.F.; Harris, P.K.; Foellmi, L.A. Glucose-6-phosphate dehydrogenase: a housekeeping enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J., 1994, 8, 174-181.
104. Galis, Z.S.; Khatri, J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res., 2002, 90, 251-262.
105. Boden, G.; Song, W.; Pashko, L.; Kresge, K. In vivo effects of insulin and free fatty acids on matrix metalloproteinases in rat aorta. Diabetes, 2008, 57, 476-483.
106. Adiels, M.; Olofsson, S.O.; Taskinen, M.R.; Boren, J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol., 2008, 28, 1225-1236.
107. Rieker, R.P.; Lee, J.C.; Downing, S.E. Positive inotropic action of insulin on piglet heart. Yale. J. Biol. Med., 1975, 48, 353-360.
108. Paulmyer-Lacroix, O.; Anglade, G.; Grino, M. Insulin-induced hypoglycaemia increases colocalization of corticotrophin-releasing factor and arginine vasopressin mRNAs in the rat hypothalamic paraventricular nucleus. J. Mol. Endocrinol., 1994, 13, 313-320.
109. Alexander, S.L.; Roud, H.K.; Irvine, C.H. Effect of insulin-induced hypoglycaemia on secretion patterns and rates of corticotrophinreleasing hormone, arginine vasopressin and adrenocorticotrophin in horses. J. Endocrinol., 1997, 153, 401-409.
110. Gonzalez-Rodriguez, E.; Gaeggeler, H.P.; Rossier, B.C. IGF-1 vs insulin: respective roles in modulating sodium transport via the PI- 3 kinase/Sgk1 pathway in a cortical collecting duct cell line. Kidney Int., 2007, 71, 116-125.
111. Staruschenko, A.; Pochynyuk, O.; Vandewalle, A.; Bugaj, V.; Stockand, J.D. Acute regulation of the epithelial Na+ channel by phosphatidylinositide 3-OH kinase signaling in native collecting duct principal cells. J. Am. Soc. Nephrol., 2007, 18, 1652-1661.
112. 2+ stores and cell responsiveness. Am. J. Physiol., 1993, 264, C1367-C1387.
113. 2+ exchanger type-1 in vascular smooth muscle. Nat. Med., 2004, 10, 1193-1199.
114. Nguyen, N.; Francoeur, N.; Chartrand, V.; Klarskov, K.; Guillemette, G.; Boulay, G. Insulin promotes the association of heat shock protein 90 with the inositol 1,4,5-trisphosphate receptor to dampen its Ca2+ release activity. Endocrinology, 2009, 150, 2190-2196.
115. Villa-Abrille, M.C.; Sidor, A.; O'Rourke, B. Insulin effects on cardiac Na+/Ca2+ exchanger activity: role of the cytoplasmic regulatory loop. J. Biol. Chem., 2008, 283, 16505-13.
116. Maier, S.; Aulbach, F.; Simm, A.; Lange, V.; Langenfeld, H.; Behre, H.; Kersting, U.; Walter, U.; Kirstein. 1999 Stimulation of Ltype Ca2+ current in human atrial myocytes by insulin. Cardiovasc. Res., 2008, 44, 390-397.
117. Lu, Z.; Jiang, Y.P.; Xu, X.H.; Ballou, L.M.; Cohen, I.S.; Lin, R.Z. Decreased L-type Ca2+ current in cardiac myocytes of type 1 diabetic Akita mice due to reduced phosphatidylinositol 3-kinase signaling. Diabetes, 2007, 56, 2780-2789.
118. Serne, E.H.; de Jongh, R.T.; Eringa, E.C.; RG, I.J.; Stehouwer, C.D. Microvascular dysfunction: a potential pathophysiological role in the metabolic syndrome. Hypertension, 2007, 50, 204-211.
119. Rask-Madsen, C.; Li, Q.; Freund, B.; Feather, D.; Abramov, R.; Wu, I.H.; Chen, K.; Yamamoto-Hiraoka, J.; Goldenbogen, J.; Sotiropoulos, K.B.; Clermont, A.; Geraldes, P.; Dall'Osso, C.; Wagers, A.J.; Huang, P.L.; Rekhter, M.; Scalia, R.; Kahn, C.R.; King, G.L. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab., 2010, 11, 379-389.
120. Little, P.J.; Ballinger, M.L.; Burch, M.L.; Osman, N. Biosynthesis of natural and hyperelongated chondroitin sulfate glycosaminoglycans: new insights into an elusive process. Open Biochem. J., 2008, 2, 135-142.
121. Ballinger, M.L.; Ivey, M.E.; Osman, N.; Thomas, W.G.; Little, P.J. Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL. Atherosclerosis, 2009, 205, 451-457.
122. Getachew, R.; Ballinger, M.L.; Burch, M.L.; Little, P.J.; Osman, N. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor- mediated proteoglycan synthesis in vascular smooth muscle cells. Eur. J. Pharmacol., 2010, 626(2-3), 186-192.
123. Ballinger, M.L.; Osman, N.; Hashimura, K.; de Haan, J.B.; Jandeleit- Dahm, K.; Allen, T.; Tannock L.R.; Rutledge, J.C.; Little, P.J. Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces Ldl binding in vitro and aortic lipid deposition in vivo. J. Cell Mol. Med., 2010, 14(6B), 1408-1418.
124. Zhuang, D.; Pu, Q.; Ceacareanu, B.; Chang, Y.; Dixit, M.; Hassid, A. Chronic insulin treatment amplifies PDGF-induced motility in differentiated aortic smooth muscle cells by suppressing the expression and function of PTP1B. Am. J. Physiol. Heart Circ. Physiol., 2008, 295, H163-H173.
125. Osman, N.; Ballinger, M.L.; Dadlani, H.M.; Getachew, R.; Burch, M.L.; Little, P.J. p38 MAP kinase mediated proteoglycan synthesis as a target for the prevention of atherosclerosis. Cardiovasc. Hematol. Disord. Drug Targets, 2008, 8, 287-292.
126. Huang, F.; Thompson, J.C.; Wilson, P.G.; Aung, H.H.; Rutledge, J.C.; Tannock, L.R. Angiotensin II increases vascular proteoglycan content preceding and contributing to atherosclerosis development. J. Lipid Res., 2008, 49, 521-530.
127. Nickenig, G.; Roling, J.; Strehlow, K.; Schnabel, P.; Bohm, M. Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms. Circulation, 1998, 98, 2453-2460.
128. Jones, B.H.; Standridge, M.K.; Taylor, J.W.; Moustaid, N. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am. J. Physiol., 1997, 273, R236-R242.
129. Liu, Z.; Cao, W. p38 mitogen-activated protein kinase: a critical node linking insulin resistance and cardiovascular diseases in type 2 diabetes mellitus. Endocr. Metab. Immune Disord. Drug Targets, 2009, 9, 38-46.
130. Baumgartl, J.; Baudler, S.; Scherner, M.; Babaev, V.; Makowski, L.; Suttles, J.; McDuffie, M.; Tobe, K.; Kadowaki, T.; Fazio, S.; Kahn, C.R.; Hotamisligil, G.S.; Krone, W.; Linton, M.; Brüning, J.C. Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE- deficient mice against atherosclerosis. Cell Metab., 2006, 3, 247-256.
131. Li, G.; Barrett, E.J.; Ko, S.H.; Cao, W.; Liu, Z. Insulin and IGF-I Receptors Differentially Mediate Insulin-Stimulated Adhesion Molecule Production by Endothelial Cells. Endocrinology, 2009, 150(8), 3475-3482.
132. Madonna, R.; Pandolfi, A.; Massaro, M.; Consoli, A.; De Caterina, R. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia, 2004, 47, 532-536.
133. Madonna, R.; Massaro, M.; Pandolfi, A.; Consoli, A.; De Caterina, R. The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells. Int. J. Immunopathol. Pharmacol., 2007, 20, 539-555.
134. Aljada, A.; Saadeh, R.; Assian, E.; Ghanim, H.; Dandona, P. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J. Clin. Endocrinol. Metab., 2000, 85, 2572-2575.
135. Suzuki, H.; Kurihara, Y.; Takeya, M.; Kamada, N.; Kataoka, M.; Jishage, K.; Ueda, O.; Sakaguchi, H.; Higashi, T.; Suzuki, T.; Takashima, Y.; Kawabe, Y.; Cynshi, O.; Wada, Y.; Honda, M.; Kurihara, H.; Aburatani, H.; Doi, T.; Matsumoto, A.; Azuma, S.; Noda, T.; Toyoda, Y.; Itakura, H.; Yazaki, Y.; Kodama, T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature, 1997, 386, 292-296.
136. Febbraio, M.; Podrez, E.A.; Smith, J.D.; Hajjar, D.P.; Hazen, S.L.; Hoff, H.F.; Sharma, K.; Silverstein, R.L. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest., 2000, 105, 1049-1056.
137. Suzuki, T.; Hiroki, A.; Watanabe, T.; Yamashita, T.; Takei, I.; Umezawa, K. Potentiation of insulin-related signal transduction by a novel protein-tyrosine phosphatase inhibitor, Et-3,4-dephostatin, on cultured 3T3-L1 adipocytes. J. Biol. Chem., 2001, 276, 27511-27518.
138. Mangeney, M.; Cardot, P.; Lyonnet, S.; Coupe, C.; Benarous, R.; Munnich, A.; Girard, J.; Chambaz, J.; Bereziat, G. Apolipoprotein- E-gene expression in rat liver during development in relation to insulin and glucagon. Eur. J. Biochem., 1989, 181, 225-230.
139. Krul, E.S.; Tang, J. Secretion of apolipoprotein E by an astrocytoma cell line. J. Neurosci. Res., 1992, 32, 227-238.
140. Ogbonna, G.; Theriault, A.; Adeli, K. Hormonal regulation of human apolipoprotein E gene expression in HepG2 cells. Int. J. Biochem., 1993, 25, 635-640.
141. Yamashita, M.; Tamasawa, N.; Matsuki, K.; Tanabe, J.; Murakami, H.; Matsui, J.; Suda, T. Insulin suppresses HDL-mediated cholesterol efflux from macrophages through inhibition of neutral cholesteryl ester hydrolase and ATP-binding cassette transporter G1 expressions. J. Atheroscler. Thromb., 2010, 17, 1183-1189.
142. Ghosh, S.; Zhao, B.; Bie, J.; Song, J. Macrophage cholesteryl ester mobilization and atherosclerosis. Vascul. Pharmacol., 2010, 52, 1-10.
143. Zhao, B.; Song, J.; Chow, W.N.; St Clair, R.W.; Rudel, L.L.; Ghosh, S. Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice. J. Clin. Invest., 2007, 117, 2983-2992.
144. Xin, C.; Yan-Fu, W.; Ping, H.; Jing, G.; Jing-Jing, W.; Chun-Li, M.; Wei, L.; Bei, C. Study of the insulin signaling pathways in the regulation of ACAT1 expression in cultured macrophages. Cell Biol. Int., 2009, 33, 602-606.
145. Xu, K.; Yang, Y.; Yan, M.; Zhan, J.; Fu, X.; Zheng, X. Autophagy plays a protective role in free cholesterol overload-induced death of smooth muscle cells. J. Lipid Res., 2010, 51, 2581-2590.
146. Federico, L.M.; Naples, M.; Taylor, D.; Adeli, K. Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory elementbinding protein-1c in the fructose-fed hamster intestine. Diabetes, 2006, 55, 1316-1326.
147. Rodriguez, A.; Duran, A.; Selloum, M.; Champy, M.F.; Diez- Guerra, F.J.; Flores, J.M.; Serrano, M.; Auwerx, J.; Diaz-Meco, M.T.; Moscat, J. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab., 2006, 3, 211-222.
148. Carlson, C.J.; Koterski, S.; Sciotti, R.J.; Poccard, G.B.; Rondinone, C.M. Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. Diabetes, 2003, 52, 634-641.
149. Stout, R.W.; Bierman, E.L.; Ross, R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ. Res., 1975, 36, 319-327.
150. Pfeifle, B.; Ditschuneit, H. The effect of insulin and insulin-like growth factors on cell proliferation of human smooth muscle cells. Artery, 1980, 8, 336-341.
151. Pfeifle, B.; Ditschuneit, H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia, 1981, 20, 155-158.
152. Pfeifle, B.; Hamann, H.; Fussganger, R.; Ditschuneit, H. Insulin as a growth regulator of arterial smooth muscle cells: effect of insulin of I.G.F.I. Diabete Metab., 1987, 13, 326-330.
153. Shrader, C.D.; Bailey, K.M.; Konat, G.W.; Cilento, E.V.; Reilly, F.D. Insulin enhances proliferation and viability of human umbilical vein endothelial cells. Arch. Dermatol. Res., 2009, 301, 159-166.
154. Chetina, E.V.; Pul, A.R. The role of growth factors in inhibition of collagen degeneration and chondrocyte differentiation in patients with osteoarthrosis. Vestn Ross Akad. Med. Nauk., 2008, (9), 40-45.
155. Martinet, W.; De Meyer, G.R. Autophagy in atherosclerosis: a cell survival and death phenomenon with therapeutic potential. Circ. Res., 2009, 104, 304-317.